Stock Analysis on Net
Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

$19.99

Adjustments to Financial Statements

Microsoft Excel LibreOffice Calc

Paying users area

Try for free

Bristol-Myers Squibb Co. pages available for free this week:

The data is hidden behind: . Unhide it.

  • Get 1-month access to Bristol-Myers Squibb Co. for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Adjustments to Current Assets

Bristol-Myers Squibb Co., adjusted current assets

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
As Reported
Current assets
Adjustments
Add: Allowance for expected credit loss
After Adjustment
Adjusted current assets

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

Adjustments to Total Assets

Bristol-Myers Squibb Co., adjusted total assets

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
As Reported
Total assets
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
Add: Allowance for expected credit loss
Less: Deferred income tax assets, non-current2
After Adjustment
Adjusted total assets

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

2 Deferred income tax assets, non-current. See details »

Adjustments to Current Liabilities

Bristol-Myers Squibb Co., adjusted current liabilities

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
As Reported
Current liabilities
Adjustments
Less: Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale)1
After Adjustment
Adjusted current liabilities

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

1 Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale). See details »

Adjustments to Total Liabilities

Bristol-Myers Squibb Co., adjusted total liabilities

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
As Reported
Total liabilities
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1
Less: Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale)2
Less: Deferred income tax liabilities, non-current3
Less: Restructuring liability
After Adjustment
Adjusted total liabilities

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale). See details »

3 Deferred income tax liabilities, non-current. See details »

Adjustments to Stockholders’ Equity

Bristol-Myers Squibb Co., adjusted total Bristol-Myers Squibb Company shareholders’ equity

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
As Reported
Total Bristol-Myers Squibb Company shareholders’ equity
Adjustments
Less: Deferred tax assets (liabilities), net1
Add: Allowance for expected credit loss
Add: Restructuring liability
Add: Noncontrolling interest
After Adjustment
Adjusted total equity

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

1 Deferred tax assets (liabilities), net. See details »

Adjustments to Capitalization Table

Bristol-Myers Squibb Co., adjusted capitalization table

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
As Reported
Short-term debt obligations
Long-term debt, excluding current portion
Total reported debt
Total Bristol-Myers Squibb Company shareholders’ equity
Total reported capital
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1
Add: Current operating lease liabilities2
Add: Non-current operating lease liabilities3
Adjusted total debt
Adjustments to Equity
Less: Deferred tax assets (liabilities), net4
Add: Allowance for expected credit loss
Add: Restructuring liability
Add: Noncontrolling interest
Adjusted total equity
After Adjustment
Adjusted total capital

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Current operating lease liabilities. See details »

3 Non-current operating lease liabilities. See details »

4 Deferred tax assets (liabilities), net. See details »

Adjustments to Reported Income

Bristol-Myers Squibb Co., adjusted net earnings (loss) attributable to BMS

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
As Reported
Net earnings (loss) attributable to BMS
Adjustments
Add: Deferred income tax expense (benefit)1
Add: Increase (decrease) in allowance for expected credit loss
Add: Increase (decrease) in restructuring liability
Add: Other comprehensive income (loss)
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest
After Adjustment
Adjusted net earnings (loss)

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

1 Deferred income tax expense (benefit). See details »